Wet Age-Related Macular Degeneration
Ophthalmology
Wet Age-Related Macular Degeneration is treated with 9 medications in our database, including Visudyne, CIMERLI, BEOVU, Byooviz, EYLEA HD, and 4 more. 4 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Bausch Lomb, Sandoz, Novartis, Samsung Bioepis, Regeneron and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Wet Age-Related Macular Degeneration treatment below.
What help exists for Wet Age-Related Macular Degeneration
9
drugs indexed
4
with copay cards
4
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Wet Age-Related Macular Degeneration
9 totalVABYSMO
Faricimab · Genentech
EYLEA
aflibercept · Regeneron
🎟💙LUCENTIS
RANIBIZUMAB · Genentech
CIMERLI
ranibizumab-eqrn · Sandoz
🎟💙EYLEA HD
aflibercept · Regeneron
🎟💙BEOVU
brolucizumab
🎟💙YARTEMLEA
narsoplimab
Visudyne
verteporfin for injection · Bausch Lomb
Byooviz
ranibizumab-nuna · Samsung Bioepis
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Wet Age-Related Macular Degeneration drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |